Geron (GERN) EBIT Margin (2010 - 2026)
Geron's (GERN) quarterly EBIT Margin came in at 21.74% in Q2 2026, up 366.0% year-over-year from 4.67% in Q2 2025, and down 7232.42% quarter-over-quarter from 0.3% in Q1 2026.
Powered by 
Analysis
Geron (GERN) EBIT Margin (2010 - 2026) Analysis & Trends
Geron has disclosed EBIT Margin across 17 years of filings, most recently posting 21.74% for Q2 2026.
- In Q2 2026, EBIT Margin rose 366.0% year-over-year to 21.74%; the TTM figure through Jun 2026 stood at 21.23% (up 2254.0% YoY), while the FY2025 annual figure was 30.74%, up 16355.0% from the prior year.
- EBIT Margin came in at 21.74% for Q2 2026 at Geron, down from 0.3% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 0.3% in Q1 2026 to a low of 236039.13% in Q4 2023.
- Average EBIT Margin over 5 years is 43197.19%, with a median of 10655.69% recorded in 2024.
- Year-over-year, EBIT Margin sank 19531000 bps in 2023 and jumped 23600569 bps in 2024.
- Over 5 years, EBIT Margin stood at 40729.13% in 2022, then slumped by 480 bps to 236039.13% in 2023, then jumped by 100 bps to 33.44% in 2024, then increased by 12 bps to 29.27% in 2025, then climbed by 26 bps to 21.74% in 2026.
- Per Business Quant data, the three most recent EBIT Margin figures were 21.74% in Q2 2026, 0.3% in Q1 2026, and 29.27% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 34.95% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -133.21% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 37.40% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 30.15% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 32.54% |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -562.07% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 17.93% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -23.56% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -25,380.93% |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - | -21.74% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -21.74% |
| Mar 31, 2026 | 0.30% |
| Dec 31, 2025 | -29.27% |
| Sep 30, 2025 | -29.40% |
| Jun 30, 2025 | -25.40% |
| Mar 31, 2025 | -42.18% |
| Dec 31, 2024 | -33.44% |
| Sep 30, 2024 | -99.80% |
| Jun 30, 2024 | -7,860.88% |
| Mar 31, 2024 | -18,465.13% |
| Dec 31, 2023 | -236,039.13% |
| Sep 30, 2023 | -29,031.71% |
| Jun 30, 2023 | -179,141.38% |
| Mar 31, 2023 | -190,914.29% |
| Dec 31, 2022 | -40,729.13% |
| Sep 30, 2022 | -13,450.51% |
| Jun 30, 2022 | -38,323.29% |
| Mar 31, 2022 | -23,313.01% |
| Dec 31, 2021 | -2,979.04% |
| Sep 30, 2021 | -23,554.13% |